Abstract
BackgroundJAK inhibitors (JAKi) are a new class of drugs developed for the treatment of different immune-mediated inflammatory diseases (IMIDs). Thrombotic events have been reported in some long-term extension studies as...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
